Last reviewed: May 30, 2026 Last updated: May 30, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
When used with insulin or sulfonylureas, these medications may increase hypoglycemia risk, requiring dose adjustments of those agents
Antiplatelet agents like aspirin and clopidogrel (Plavix) operate through different mechanisms than anticoagulants and carry lower interaction risk with semaglutide
Its a much simpler concept than it sounds
Its being tested for its potential in weight loss and diabetes management, but its availability is limited to research settings
People should not take this medication with drinks other than water